期刊文献+

纳米碳示踪技术在胰腺癌根治术中的应用探讨 被引量:3

Application of Carbon Nanoparticles Tracer Technique in Radical Resection of Pancreatic Cancer
原文传递
导出
摘要 目的探讨纳米碳示踪技术在胰腺癌根治术中的应用价值。方法回顾性分析2013年6月至2016年12月间52例胰腺癌患者的资料,分为纳米碳组和对照组,各26例,纳米碳组术中应用纳米碳示踪剂治疗,对照组则不给予。采用SPSS22.0软件进行统计学分析,围手术期相关指标、淋巴结检获数目和生存时间采用(x±s)表示,独立样本t检验;术后淋巴结阳性比率和并发症发生率比较采用χ2检验,生存率比较用Kaplan-Meier检验,P<0.05差异有统计学意义。结果两组患者手术时间、术中出血量、术后引流量、平均住院时间比较,差异无统计学意义(P>0.05);纳米碳组淋巴结检获数目(26.3±2.5)枚,明显多于对照组(19.4±1.7)枚,其中微小淋巴结(≤5 mm)(8.1±1.7)枚,明显多于对照组(5.3±1.0)枚;纳米碳组阳性淋巴结(11.4±3.1)枚,明显多于对照组(5.9±1.5)枚;检出所需时间(20.4±3.6)min,明显短于对照组(31.8±5.1)min(P<0.05);纳米碳组阳性淋巴结比率为19.5%(168/860),高于对照组的15.7%(115/733)(P<0.05);纳米碳组黑染率为71.2%(612/860),黑染淋巴结阳性比率24.1%(148/612),明显高于未黑染淋巴结阳性比率8.1%(20/248)和对照组淋巴结阳性比率(P<0.05)。纳米碳组第1年、2年、3年的生存率均明显高于对照组(P<0.05);纳米碳组术后平均生存时间为(25.0±13.3)个月,明显多于对照组(15.3±13.0)个月(P<0.05)。结论纳米碳示踪技术应用于胰腺癌根治术可取得良好的淋巴结示踪效果,明显提高淋巴结的检出数目和阳性淋巴结的清扫率,提高术后生存时间,改善患者预后。 Objective To investigate the effect of carbon nanoparticles tracer technique in radical resection of pancreatic cancer. Methods From June 2013 to December 2016, a retrospective analysis was performed in 52 patients with pancreatic cancer treated in our hospital, the patients were divided into carbon nanoparticle group and control group, 26 cases in each group, carbon nanoparticle lymphatic tracer was used in carbon nanoparticle group during operation. Statistical analysis was performed by SPSS 22.0 software, the perioperative indicators, number of lymph nodes and survival time were expressed as mean±standard deviation , and were examined by using t test. The positive lymph node ratio and post-operative complication rate were examined by using chi square test. The survival rate were examined by using Kaplan-Meier test. A P value of 〈0.05 was considered as significant difference. Results There were no significant differences in the operation time, amount of post-operation drainage, intraoperative blood loss and average hospitalization time between the two groups ( P 〉0.05). The average number of lymph nodes in carbon nanoparticle group (26.3±2.5) was significantly more than that (19.4±1.7) in the control group, and the number of lymph nodes whose diameter were less than 5 mm was significantly more than that in the control group[(8.1±1.7) vs. (5.3±1.0)], the average number of positive lymph nodes in carbon nanoparticle group (11.4±3.1) was significantly more than that (5.9±1.5) in control group; The mean required time for lymph nodes detection in carbon nanoparticle group (20.4±3.6) min was significantly shorter than that in control group (31.8±5.1) min. The positive lymph node ratio in carbon nanoparticle group (19.5%, 168/860) was significantly higher than that in control group (15.7%, 115/733). The rate of black-dyed lymph nodes in carbon nanoparticle group was (71.2%, 612/860). The positive lymph node ratio of black-dyed lymph nodes (24.1%,148/612) was significantly higher than that of non-black-dyed lymph nodes(8.1%,20/248) and the control group ( P 〈0.05). The 1-,2-,3- years survival rate in carbon nanoparticle group were higher than those in control group ( P 〈0.05). The mean survival time of carbon nanoparticle group (25.0± 13.3 months) was significantly more than that of the control group (15.3±13.0 months) ( P 〈0.05) . Conclusion The application of carbon nanoparticles tracer technique in radical resection of pancreatic cancer can reach good effect, which increased the number of lymph node and positive lymph node dissection rate, improved the survival time and prognosis of patients.
作者 胡伟 张桢 沈丰 周文波 Hu Wei;Zhang Zhen;Shen Feng;Zhou Wenbo(Department of Hepatobiliary Surgery,Dongfeng Hospital Affiliated to Hubei Medical College,Shiyan Hubei 442000,China)
出处 《中华普外科手术学杂志(电子版)》 2018年第5期424-427,共4页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
关键词 胰腺肿瘤 纳米管 淋巴结 胰腺切除术 Pancreatic Neoplasms Nanotubes Carbon Lymph Nodes Pancreatectomy
  • 相关文献

参考文献13

二级参考文献98

  • 1孙维佳,肖君,谢虹.VEG-FC,Flt4在胰腺癌中的表达及临床意义[J].中国普通外科杂志,2005,14(6):465-467. 被引量:3
  • 2徐少杰,黎庆荣,龚伟,纪建松.胃癌淋巴结大小与转移的关系[J].肿瘤学杂志,2005,11(6):447-448. 被引量:13
  • 3Zhang J, Zhou Y, Jiang K, et al. Evaluation of the seventh AJCC TNM staging system for gastric cancer a meta - analysis of cohort studies [J]. Tumour Biol, 2014, 35 (9): 8525-8532.
  • 4Hanna GB, Amygdalos I, Ni M, et al. Improving the standard of lymph node retrieval after gastric cancer surgery [ J]. Histopathology, 2013, 63 (3): 316-324.
  • 5Wu CY, Chen JT, Chen GH, et al. Lymph node metastasis in early gastric cancer: a clinicopathological analysis [ J ]. Hepatogastroenterology, 2002, 49 (47) : 1465 - 1468.
  • 6Alatengbaolide, Lin D, Li Y, et al. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes [J]. Am J Clin Oncol, 2013, 36 (4) : 325 -330.
  • 7Ichikawa D, Kurioka H, Ueshima Y, et al. Prognostic value of lymph node staging in gastric cancer [ J ]. Hepatogastroenterology,2003, 50 (49): 301-304.
  • 8Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer [J]. Ann Surg Oncol, 2007, 14 (5) : 1688 -1693.
  • 9Espfn F, Bianchi A, Llorca S, et al. Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer [J]. Eur J Surg Oneol, 2012, 38 (6) : 497 -502.
  • 10Fiorito S, Serafino A, Andreola F, ct al. Toxicity and biocompatibility of carbon nanoparticles [J]. J Nanosci Nanotechnol, 2006, 6 (3): 591- 599.

共引文献144

同被引文献31

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部